Skip to main content

US ClosedU.S. Closed

Healthcare · Biotechnology

HCW Biologics Inc. operates as a preclinical-stage biopharmaceutical firm, primarily engaged in the discovery and advancement of novel immunotherapies.

52W Range

5thpctl

Volume

0.06×avg

Market Cap

1.19MUSD

P/E Ratio

-0.1TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

HCW Biologics Inc.

HCWBNASDAQ Global Market·USD·Closed

HCW Biologics Inc.

HCWBNASDAQ·USD·Closed

$3.43

+8.20%

$3.43

+$0.26 (8.20%)

52W Range

5thpctl

Volume

0.06×avg

Mkt Cap

1.19MUSD

P/E

-0.1TTM

Div Yield

–ann

HCWB: HCW Biologics Inc. Stock Analysis | finqOS